ViewsML - About the company
ViewsML is a seed company based in Vancouver (Canada), founded in 2022 by Rafay A. It operates as an AI-powered platform for drug development and companion diagnostics. ViewsML has raised $3.58M in funding from Wittington Ventures. The company has 298 active competitors, including 86 funded and 16 that have exited. Its top competitors include companies like PathAI, Lunit and Aiforia.
Company Details
AI-powered platform for drug development and companion diagnostics. The company's key platform technology, Aion, virtualizes the IHC process to forecast biomarker expression spatially and increase efficiencies in drug discovery, as well as hasten patient selection in clinical trials.
- Website
- www.viewsml.com/
- Email ID
- *****@viewsml.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2022
Location
Vancouver, Canada
Stage
Seed
Total Funding
$3.58M in 2 rounds
Latest Funding Round
Investors
Ranked
50th among 298 active competitors
Employee Count
16 as on Sep 30, 2026
Sign up to download ViewsML's company profile
ViewsML's funding and investors
ViewsML has raised a total funding of $3.58M over 2 rounds. Its first funding round was on 2024. Its latest funding round was a Seed round on Apr 20, 2026 for $*****. 8 investors participated in its latest round. ViewsML has 10 institutional investors.
Here is the list of recent funding rounds of ViewsML:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 20, 2026 | 4969790 | Seed | 4442571 | 1902689 | 7758997 | 7867185 |
2024 | 9367 | Seed | 5494 | 7426 | 2115 |
Access funding benchmarks and valuations. Sign up today!View details of ViewsML's funding rounds and investors
ViewsML's founders and board of directors
Founder? Claim ProfileThe founders of ViewsML is Rafay A. Kenneth To is the CEO of ViewsML.
Here are the details of ViewsML's key team members:
- Rafay A: Co-Founder of ViewsML.
- Kenneth To: CEO of ViewsML.
View details of ViewsML's Founder profiles and Board Members
ViewsML's employee count trend
ViewsML has 16 employees as of Sep 26. Here is ViewsML's employee count trend over the years:
Uncover ViewsML's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ViewsML's Competitors and alternates
Top competitors of ViewsML include PathAI, Lunit and Aiforia. Here is the list of Top 10 competitors of ViewsML, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  PathAI 2016, Boston (United States), Series C | Provider of digital pathology image management system for clinical labs | $255M | 72/100 | |
2nd | Lunit 2013, Seoul (South Korea), Public | Developer of medical software for cancer screening and oncology diagnostics | $135M | 67/100 | |
3rd | Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas | $23M | 66/100 | ||
4th | Provider of AI-powered diagnostic solutions for pathology | $114M | 64/100 | ||
5th |  Valar Labs 2021, Palo Alto (United States), Series A | Developer of AI diagnostics for predicting cancer treatment response likelihood | $26.1M | 62/100 | |
6th | Techcyte 2014, Orem (United States), Series B | Artificial intelligence (AI) based image analysis platform for pathologists | $50.4M | 62/100 | |
7th | Proscia 2014, Philadelphia (United States), Acquired | Provider of an AI and cloud-based digital pathology solution for cancer diagnosis | $129M | 62/100 | |
8th |  Nucle AI 2017, Chicago (United States), Series B | AI-assisted platform for image analysis | $60M | 61/100 | |
9th |  Aignostics 2018, Berlin (Germany), Series B | Developer of artificial intelligence software for biomedical image analysis applications | $53.9M | 61/100 | |
10th | Developer of AI-based radiology image solutions primarily for cancer diagnosis | $115M | 59/100 | ||
50th | AI-powered platform for drug development and companion diagnostics | $3.58M | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ViewsML's competitors? Click here to see the top ones
ViewsML's Investments and acquisitions
ViewsML has made no investments or acquisitions yet.
Reports related to ViewsML
Here is the latest report on ViewsML's sector:
News related to ViewsML
Media has covered ViewsML for 1 event in last 1 year.
•
ViewsML Raises $4.9M in Seed FundingFinSMEs•Apr 20, 2026•Defined Capital, ViewsML, RiSC Capital, Mayo Clinic and 5 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about ViewsML
Explore our recently published companies
- nameless - Scottsdale based, Unfunded company
- MYI - Zurich based, 2016 founded, Unfunded company
- MVA Wellness - Ashburn based, Unfunded company
- Virgool Agency - Iran based, 2016 founded, Public company
- Dr. Gadget-Phone and Tablet Repair - Aurora based, 2014 founded, Unfunded company
- myConsultor - Unfunded company
